On March 27, 2024, Ayala Pharmaceuticals, Inc. and Roy Golan, Chief Financial Officer, agreed that Mr. Golan would depart the Company on June 25, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.25 USD | +16.28% | +13.64% | -62.52% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-62.52% | 10.66M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Ayala Pharmaceuticals, Inc. Announces Departure of Roy Golan as Chief Financial Officer, Effective from June 25, 2024